Anna Runström

946 total citations
15 papers, 687 citations indexed

About

Anna Runström is a scholar working on Immunology, Transplantation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anna Runström has authored 15 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Transplantation and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anna Runström's work include Renal Transplantation Outcomes and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (3 papers). Anna Runström is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (3 papers). Anna Runström collaborates with scholars based in Sweden, United States and France. Anna Runström's co-authors include Lennart Ohlsson, Gunnar Hedlund, Christian Kjellman, Lena Winstedt, Thomas Brodin, Charlott Brunmark, Birgitta Sparre, Mikael Åström, Anna Miller‐Larsson and Ralph Brattsand and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Anna Runström

14 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Runström Sweden 10 237 142 141 139 87 15 687
Fabrizio Scatena Italy 17 162 0.7× 50 0.4× 122 0.9× 57 0.4× 154 1.8× 35 632
Xiaojuan Wu China 17 181 0.8× 57 0.4× 229 1.6× 19 0.1× 98 1.1× 42 706
A. Christopher Stevens United States 11 304 1.3× 71 0.5× 111 0.8× 67 0.5× 231 2.7× 13 789
Patrizia Pellegrini Italy 15 405 1.7× 154 1.1× 292 2.1× 27 0.2× 64 0.7× 51 968
Anna Maria Berghella Italy 15 384 1.6× 128 0.9× 142 1.0× 27 0.2× 52 0.6× 38 714
Fumin Fu United States 16 938 4.0× 35 0.2× 249 1.8× 140 1.0× 101 1.2× 27 1.5k
M Dimitrijevic Serbia 9 111 0.5× 82 0.6× 135 1.0× 28 0.2× 44 0.5× 18 525
Enrique Colado Spain 16 165 0.7× 41 0.3× 241 1.7× 34 0.2× 62 0.7× 35 683
Dameng Lian Canada 15 378 1.6× 56 0.4× 260 1.8× 67 0.5× 55 0.6× 21 724
Lynne P. Rutzky United States 12 91 0.4× 34 0.2× 261 1.9× 286 2.1× 37 0.4× 18 893

Countries citing papers authored by Anna Runström

Since Specialization
Citations

This map shows the geographic impact of Anna Runström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Runström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Runström more than expected).

Fields of papers citing papers by Anna Runström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Runström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Runström. The network helps show where Anna Runström may publish in the future.

Co-authorship network of co-authors of Anna Runström

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Runström. A scholar is included among the top collaborators of Anna Runström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Runström. Anna Runström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Jaffe, Ian, Anna Runström, Vasishta Tatapudi, et al.. (2025). Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase Desensitization. Transplantation Direct. 11(2). e1752–e1752.
2.
Halleck, Fabian, Georg A. Böhmig, Lionel Couzi, et al.. (2024). A Randomized Trial Comparing Imlifidase to Plasmapheresis in Kidney Transplant Recipients With Antibody‐Mediated Rejection. Clinical Transplantation. 38(7). e15383–e15383. 9 indexed citations
3.
Kjellman, Christian, Angela Q. Maldonado, Bonnie E. Lonze, et al.. (2021). Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients. American Journal of Transplantation. 21(12). 3907–3918. 50 indexed citations
4.
Runström, Anna, et al.. (2021). IgM single antigen bead HLA-assay is affected by imlifidase through the cleavage of IgG but not IgM. Transplant Immunology. 68. 101436–101436. 1 indexed citations
5.
Bockermann, Robert, Sofia Järnum, Anna Runström, et al.. (2021). Imlifidase-generated Single-cleaved IgG: Implications for Transplantation. Transplantation. 106(7). 1485–1496. 12 indexed citations
6.
Jordan, Stanley C., Christophe Legendre, Niraj M. Desai, et al.. (2020). Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes). Transplantation. 105(8). 1808–1817. 66 indexed citations
7.
Järnum, Sofia, Anna Runström, Robert Bockermann, et al.. (2017). Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy. Molecular Cancer Therapeutics. 16(9). 1887–1897. 9 indexed citations
8.
Winstedt, Lena, Sofia Järnum, Emma Andersson Nordahl, et al.. (2015). Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS – A Novel Therapeutic Opportunity. PLoS ONE. 10(7). e0132011–e0132011. 81 indexed citations
9.
Järnum, Sofia, Robert Bockermann, Anna Runström, Lena Winstedt, & Christian Kjellman. (2015). The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation. The Journal of Immunology. 195(12). 5592–5601. 39 indexed citations
10.
Runström, Anna, Tomas Leanderson, Lennart Ohlsson, & Bengt Axelsson. (2006). Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-β k.o. and wild type mice. Journal of Neuroimmunology. 173(1-2). 69–78. 49 indexed citations
11.
Andersson, Gunnar, Tomas Fex, Gunnar Hedlund, et al.. (2004). Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders:  Structure−Activity Relationship. Journal of Medicinal Chemistry. 47(8). 2075–2088. 131 indexed citations
12.
Brunmark, Charlott, Anna Runström, Lennart Ohlsson, et al.. (2002). The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 130(1-2). 163–172. 145 indexed citations
13.
Pettersson, U., et al.. (2001). Interference with CD28, CD80, CD86 or CD152 in Collagen-induced Arthritis. Limited Role of IFN-γ in Anti-B7-mediated Suppression of Disease. Journal of Autoimmunity. 17(1). 39–50. 18 indexed citations
14.
Miller‐Larsson, Anna, Paul Jansson, Anna Runström, & Ralph Brattsand. (2000). Prolonged Airway Activity and Improved Selectivity of Budesonide Possibly Due to Esterification. American Journal of Respiratory and Critical Care Medicine. 162(4). 1455–1461. 69 indexed citations
15.
Miller‐Larsson, Anna, Anna Runström, & Ralph Brattsand. (1999). Adrenalectomy permits a late, local TNF‐α release in LPS‐challenged rat airways. European Respiratory Journal. 13(6). 1310–1310. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabrizio Scatena Breakdown of academic impact, for papers by Xiaojuan Wu Breakdown of academic impact, for papers by A. Christopher Stevens Breakdown of academic impact, for papers by Patrizia Pellegrini Breakdown of academic impact, for papers by Anna Maria Berghella Breakdown of academic impact, for papers by Fumin Fu Breakdown of academic impact, for papers by M Dimitrijevic Breakdown of academic impact, for papers by Enrique Colado Breakdown of academic impact, for papers by Dameng Lian Breakdown of academic impact, for papers by Lynne P. Rutzky
Rankless by CCL
2026